IV Synercid

November 1999

Rhone-Poulenc Rorer is now marketing IV Synercid.

It's the new antibiotic of "last resort"...for vancomycin-resistant Enterococcus faecium (VREF).

Synercid is actually a combination of two antibiotics...quinupristin and dalfopristin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote